Please enable javascript for best website experience

Fully informed.

The Task Force on Infectious Disease Preparedness and Response is comprised of experts and professionals from highly respected Texas institutions. The task force exists to provide critical information and recommendations regarding the risks of infectious diseases to Texas citizens.

Stay Informed

Always prepared.

Understanding proper procedure and best practices can make all the difference in a variety of medical scenarios. To help protect you and the health of those around you, TexasIDR provides free training materials, online courses, opportunities to engage with the healthcare community, and free continuing education credits for medical professionals and first responders.

View Courses

OUR MISSION

A statewide work group of health professionals that will gather, review, and post educational resources for multiple audiences on preparedness and response to emerging and important infectious diseases, such as Ebola.

Courses

To help prevent the spread of infectious diseases, check out the informative and instructional courses available through TexasIDR. Courses are open and free to anybody and CE, CME, and CNE credit is offered upon completion of each module. Please click on the modules below to join the TXIDR community and get started.

view all courses

Featured Courses

New Antifungal Agents
This online enduring material will provide vital information on new antifungal agents and their toxicities and limitations as well as gaps in antifungal therapy which require new antifungal agents.
   36 minutes
View course
Infections Associated with the Use of Novel Cancer Therapies
This online enduring material will provide vital information on infections associated with the use of novel cancer therapies.
   37 minutes
View course
Top Stories
Mayaro virus disease - French Guiana, France
On 13 October 2020, the French health authorities officially reported 13 laboratory-confirmed cases of Mayaro fever in French Guiana, France. In September 2020, the Institut Pasteur de la Guyane (IPG) (member of the French National Reference Laboratory for arboviruses) identified two cases of Mayaro virus infection (MAYV) confirmed by reverse transcriptase polymerase chain reaction (RT-PCR) and one probable case found positive for Mayaro antibodies. The case-patients presented dengue-like symptoms and joint pains, and tested negative for dengue by RT-PCR.
read more
Oropouche virus disease - French Guiana, France
On 30 September 2020, the French Guiana Regional Health Agency (ARS) reported the first detection of Oropouche virus (OROV) in French Guiana. On 22 September 2020 the Pasteur Institute in Cayenne (a member of the French National Reference Laboratory for arboviruses) notified the France IHR National Focal Point of seven laboratory-confirmed cases of Oropouche virus infection in the village of Saül. These cases were identified following clinical investigations of an unusually high number of dengue-like illnesses in the village. Between 11 August and 25 September, there were 37 clinically-compatible cases of Oropouche virus disease identified in Saül. The results of serology for dengue, chikungunya, and Zika were negative, and seven of nine cases tested positive for OROV by reverse transcriptase polymerase chain reaction (RT-PCR). Among the 37 clinically-compatible cases, most cases are male (60%) and the median age is 36 years (range 3-82 years). The most represented age range is 15 to 54-years-old (19 cases) followed by 0 to 14-years-old (10 cases). A peak of cases was observed in mid-September however, the outbreak investigation remains ongoing.
read more
Monkeypox – Democratic Republic of the Congo
From 1 January through 13 September 2020, a total of 4,594 suspected cases of monkeypox, including 171 deaths (case fatality ratio 3.7%), have been reported in 127 health zones from 17 out of 26 provinces in the Democratic Republic of the Congo. The first epidemic peak was observed at the beginning of March 2020 (epi week 10), with 136 cases reported weekly (Figure1). From 1 January through 7 August, the Institut National de Recherche Biomédicale (INRB) received 80 samples from suspected cases of monkeypox, of which 39 samples were confirmed positive by polymerase chain reaction. Four out of the 80 specimens were skin lesions (crusts/vesicles), the remaining samples were blood. There is no further information at this time regarding the outcome of these 80 patients whose samples were tested. Confirmatory testing remains ongoing. During the same period in 2019, 3,794 suspected cases and 73 deaths (CFR 1.9%) were reported in 120 health zones from 16 provinces while a total of 2,850 suspected cases (CFR 2.1%) were reported in 2018.
read more
Stay Informed

Sign up for text alerts
Text "txidr" to 21000
Sign up for updates from TexasIDR